Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. - Wikidata - awgldk - TriplyDB

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

http://www.wikidata.org/entity/Q33518322

about

New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation Five-year visual outcome following laser photocoagulation of diabetic macular oedema.Diabetic retinopathy (treatment)Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial Corticosteroid use for diabetic macular edema: old fad or new trend?Correlation Between the Findings of Optical Coherent Retinal Tomography (OCT), Stereo Biomicroscopic Images from Fundus of an Eye and Values from Visual Acuity of Diabetic Macular Edema.Pathophysiology and treatment of diabetic retinopathy.Current treatments in diabetic macular oedema: systematic review and meta-analysis Evolving strategies in the management of diabetic retinopathy A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network Effect of focal laser photocoagulation in eyes with mild to moderate non-proliferative diabetic retinopathy.Corticosteroid Treatment in Diabetic Macular Edema.Nonsteroidal anti-inflammatory drugs for retinal disease.Nerve growth factor promotes endothelial progenitor cell-mediated angiogenic responses Pronerve growth factor induces angiogenesis via activation of TrkA: possible role in proliferative diabetic retinopathy.Delivery of steroids into the eye for the treatment of macular edema.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study).Diabetic retinopathy: research to clinical practice.Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population.Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.

P2860

Q26765468-D77FEDBB-A014-43D7-8A15-868677A14A74 Q33843242-9B52FFCF-9094-4A6F-A143-706486BDF870 Q33903781-84BE017E-99F9-435F-976B-CD82219E887A Q33910631-B62F00AF-4038-4391-B8DF-DD4C868E0B71 Q34170485-D971B263-1332-48EB-AA93-F61351A4EE35 Q34267270-2A95C5FD-F114-47B2-9D2E-F4EC41634260 Q34436760-8C31FE64-78D0-499C-B3B5-CF21E91220C8 Q34528134-E0CD30FC-6B8A-4172-9B5F-C7909B0A4C0E Q34606190-0F996A78-6A64-4DBE-B9FD-6E01B8B23C0E Q35067102-1AA1AB9D-CBD5-444B-BC82-B68BAF7570B8 Q35592903-42D714D0-2F17-44C9-806C-38813EC16FBB Q35649512-F4C37956-2483-4911-B184-B96BC0B4A52B Q36179824-B2EEFC8B-018F-4FB2-BFEF-FFDF010701F3 Q36409906-2598FA12-F5C1-4562-9784-AA29D3B27F9E Q36567310-53FFA241-6024-4D58-97B3-EEC81B86D19C Q37013867-F9DEC78A-1FF0-4BB3-BA16-424E95EB7DE1 Q37122419-EF17B730-8491-412A-BFD8-8E774D7169CC Q38815223-2529DED4-BD2E-4487-B1AD-C19A5F0E9CF3 Q39103248-20E8126A-8510-4CC0-87AE-B2F6948F5F29 Q41939283-4034758C-EF6F-45D6-BDB9-E88C24378BF0 Q42672190-33D41F4E-DB31-456B-B4E2-7163012804BD Q47108294-5C3C56A3-A9AE-4E8C-B934-B47645A266EE Q55312812-8B86844B-C259-49D4-A3CF-66F027A3287C

P2860

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

http://www.wikidata.org/entity/Q33518322

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@ast

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@en

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@nl

type

label

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@ast

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@en

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@nl

prefLabel

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@ast

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@en

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@nl

P1433

Q33518322-60EE59D8-9DDB-47FA-BCAC-45A03A3A091A

P1476

Q33518322-6E8CE1D9-5DBA-456F-AE5F-CC78CF48D18C

P2093

Q33518322-312C6816-8A76-44F0-AA30-A6EDF33F0288

Q33518322-3CD5ED1B-7D34-44FF-A066-85D529BCEF35

Q33518322-52A991A3-A438-4A8F-9BDF-713C7A6971E3

Q33518322-62BA92D0-31A4-43B6-BE89-48D9ABF4AAFD

Q33518322-6BDC1B54-EB1B-4821-8469-02FFE501B3F1

Q33518322-7AAAE12D-740D-464B-88A3-BA58D2C50A47

Q33518322-8D94F385-8FE8-479B-8C23-AB250DA4730D

Q33518322-AE7225E7-51DC-4D85-B41F-19935C5034EC

Q33518322-CB6FAC6D-48BA-4055-A9C8-6A410684DCAF

Q33518322-D360A829-5435-4B02-9EE6-2383663E4164

P2860

Q33518322-0033BB21-3C67-4DD7-B04D-D7346A7F6AC1

Q33518322-11EC87A8-8F23-4560-87F6-B66696A4D706

Q33518322-2135E032-A279-446D-BFF4-AA2452B5BF74

Q33518322-2B8A3EDD-9033-4E5C-B58D-C95FB9F7BC3E

Q33518322-34827263-B21E-4106-8EDD-CEF46D4F280D

Q33518322-5EF0C314-015B-49DD-A4E1-480805662645

Q33518322-68852396-5FC0-41C9-B2EA-913678A7DDE5

Q33518322-71E5FE38-A294-4DD6-9341-8DE132836B84

Q33518322-72F7E40A-20D1-40AD-B67E-8CB377277AF5

Q33518322-83FC7E0D-8F70-442D-87E6-69E9EEC875F2

P304

Q33518322-454422B0-49A7-427E-827E-6EB68CF80FFC

P31

Q33518322-3E0E7DCC-80CD-43DE-A117-B2C1C6529317

P356

Q33518322-C86192E7-FA38-4192-B150-2E559985FE3B

P407

Q33518322-372CB68F-6887-4AC1-AEB4-CE1D7F2F402B

P433

Q33518322-7A24D8BF-3742-495C-865E-23EB89834F54

P478

Q33518322-52AB4A76-85EE-4626-B7FB-CF742A71E086

P577

Q33518322-B79B53AF-5B90-4D7D-8567-57989104119D

P5875

Q33518322-FB122B18-95C9-4514-A445-D81C8C131F59

P698

Q33518322-2B5677C0-A0E2-499F-B7EB-4D89B337AE61

P921

Q33518322-2CC0EF62-CC0D-4EDB-A799-76081A422D53

P932

Q33518322-84ED938A-7766-49D4-9396-D5F6F2A1DD61

P356

ARCHOPHTHALMOL.2009.308

P1433

JAMA Ophthalmology

P1476

Exploratory analysis of diabet ...... h focal/grid photocoagulation.

@en

P2093

Adam R Glassman

http://www.w3.org/2001/XMLSchema#string

Allison R Edwards

http://www.w3.org/2001/XMLSchema#string

Baruch D Kuppermann

http://www.w3.org/2001/XMLSchema#string

Christina J Flaxel

http://www.w3.org/2001/XMLSchema#string

Craig Kollman

http://www.w3.org/2001/XMLSchema#string

Diabetic Retinopathy Clinical Research Network

http://www.w3.org/2001/XMLSchema#string

Michael S Ip

http://www.w3.org/2001/XMLSchema#string

Neil M Bressler

http://www.w3.org/2001/XMLSchema#string

Roy W Beck

http://www.w3.org/2001/XMLSchema#string

Thomas W Stone

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor angiogenesis: therapeutic implications

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study

Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.

Macular edema. A complication of diabetic retinopathy.

Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.

Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.

P304

1566-1571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHTHALMOL.2009.308

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40686432

http://www.w3.org/2001/XMLSchema#string

P698

20008708

http://www.w3.org/2001/XMLSchema#string

P921

Light Coagulation

P932

2872985

http://www.w3.org/2001/XMLSchema#string